Indian Dermatology Online Journal

DRUG PROFILE
Year
: 2020  |  Volume : 11  |  Issue : 3  |  Page : 453--464

Hydroxychloroquine in dermatology and beyond: Recent update


Kabir Sardana, Surabhi Sinha, Soumya Sachdeva 
 Department of Dermatology, STD and Leprosy, Atal Bihari Vajpayee Institute of Medical Sciences (ABVIMS) (PGIMER), Dr. Ram Manohar Lohia Hospital, New Delhi, India

Correspondence Address:
Surabhi Sinha
Room 205, Academic Block, Atal Bihari Vajpayee Institute of Medical Sciences (ABVIMS) (PGIMER), Dr. Ram Manohar Lohia Hospital, New Delhi - 110 001
India

Hydroxychloroquine is one of the most frequently used drugs in dermatology with a wide variety of uses due to its immunomodulatory, anti-inflammatory, photoprotective, and metabolic actions and low side effect profile. Demonstration of its antiviral action in vitro has led to renewed interest by physicians worldwide during the ongoing coronavirus disease of 2019 (COVID-19) pandemic. Like its immunomodulatory action, its antiviral activity is also due to its ability to alkalinize the intracytoplasmic milieu, leading to disordered viral entry/fusion and deranged viral protein synthesis. However, randomized controlled trials are the need of the hour to conclusively determine its clinical efficacy in such infections. A review of the multitude of mechanisms of action, updated screening and monitoring guidelines, drug interactions, side effects, and its use in special populations is presented.


How to cite this article:
Sardana K, Sinha S, Sachdeva S. Hydroxychloroquine in dermatology and beyond: Recent update.Indian Dermatol Online J 2020;11:453-464


How to cite this URL:
Sardana K, Sinha S, Sachdeva S. Hydroxychloroquine in dermatology and beyond: Recent update. Indian Dermatol Online J [serial online] 2020 [cited 2020 Oct 21 ];11:453-464
Available from: https://www.idoj.in/article.asp?issn=2229-5178;year=2020;volume=11;issue=3;spage=453;epage=464;aulast=Sardana;type=0